Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational studyR Venegas-Rodriguez, María del Carmen Domínguez-Horta, Ruben Peña-Ruiz et al.|PLoS ONE|2023Cited by 7